Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder

Groenman, Annabeth P.; Oosterlaan, Jaap; Rommelse, Nanda N. J.; Franke, Barbara; Greven, Corina U.; Hoekstra, Pieter J.; Hartman, Catharina A.; Luman, Marjolein; Roeyers, Herbert; Oades, Robert D.; Sergeant, Joseph A.; Buitelaar∗, Jan K.; Faraone∗, Stephen V.

doi:10.1192/bjp.bp.112.124784

Cited by 85Attention Deficit Hyperactivity DisorderSubstance Abuse Treatment and OutcomesChild and Adolescent Psychosocial and Emotional Development

Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder

Open access

Groenman, Annabeth P., Oosterlaan, Jaap, Rommelse, Nanda N. J., Franke, Barbara, Greven, Corina U., Hoekstra, Pieter J., Hartman, Catharina A., Luman, Marjolein +5 more·2013·British Journal of Psychiatry

DOI 10.1192/bjp.bp.112.124784

Open this paper in CoChat — free account Open PDF

Abstract

Background: Attention-deficit hyperactivity disorder (ADHD) is linked to increased risk for substance use disorders and nicotine dependence. Aims: To examine the effects of stimulant treatment on subsequent risk for substance use disorder and nicotine dependence in a prospective longitudinal ADHD case–control study. Method: At baseline we assessed ADHD, conduct disorder and oppositional defiant disorder. Substance use disorders, nicotine dependence and stimulant treatment were assessed retrospectively after a mean follow-up of 4.4 years, at a mean age of 16.4 years. Results: Stimulant treatment of ADHD was linked to a reduced risk for substance use disorders compared with no stimulant treatment, even after controlling for conduct disorder and oppositional defiant disorder (hazard ratio (HR) = 1.91, 95% Cl 1.10−3.36), but not to nicotine dependence (HR = 1.12, 95% Cl 0.45−2.96). Within the stimulant-treated group, a protective effect of age at first stimulant use on substance use disorder development was found, which diminished with age, and seemed to reverse around the age of 18. Conclusions: Stimulant treatment appears to lower the risk of developing substance use disorders and does not have an impact on the development of nicotine dependence in adolescents with ADHD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1192/bjp.bp.112.124784

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

More recent studies report that medication treatment is linked to lower substance-related risk.
“In fact, several more recent studies have found that medication treatment is associated with decreased substance-related risk (18–20).”
From ADHD Medication and Substance-Related Problems (2017) · cites this paper as [18]
Experimental — accuracy not yet measured
Stimulant use in childhood has neutral or protective effects on subsequent drug and alcohol use disorders.
“neutral or protective effects on sub sequent drug and alcohol use disorders 172-175 .”
From Attention-deficit/hyperactivity disorder (2015) · cites this paper as [174]
In a prospective follow-up study by Groenman et al. (2013), stimulant treatment of childhood ADHD was associated with a lower risk of later SUD, but not of nicotine dependence, even after controlling for comorbid CD (HR = 1.91).
“In a prospective follow-up study by Groenman et al. (2013), stimulant treatment of childhood ADHD was associated with a lower risk of later SUD, but not of nicotine dependence, even after controlling for comorbid CD (HR = 1.91) [57].”
From Treatment of Adolescents with Concurrent Substance Use Disorder and Attention-Deficit/Hyperactivity Disorder: A Systematic Review (2021) · cites this paper as [57]
Stimulant treatment of ADHD may reduce the risk of developing SUD.
“Stimulant treatment of ADHD may also reduce the risk of developing SUD”
From Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder. (2016) · cites this paper as [52]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Applied logistic regression
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305 · see citing works
Applied Logistic Regression
Hosmer, D. W., & Lemeshow, S. (2000) · doi:10.1002/0471722146 · Cited by 20,302 · see citing works
Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption‐II
SAUNDERS, J. B., AASLAND, O. G., BABOR, T. F., DE LA FUENTE, J. R., & GRANT, M. (1993) · Addiction · doi:10.1111/j.1360-0443.1993.tb02093.x · Cited by 13,482 · see citing works
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738 · see citing works
Untitled work
(1967) · Project Euclid (Cornell University) · Cited by 4,720 · see citing works
NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): Description, Differences From Previous Versions, and Reliability of Some Common Diagnoses
SHAFFER, D., FISHER, P., LUCAS, C. P., DULCAN, M. K., & SCHWAB-STONE, M. E. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200001000-00014 · Cited by 3,505 · see citing works
Akaike's Information Criterion in Generalized Estimating Equations
Pan, W. (2001) · Biometrics · doi:10.1111/j.0006-341x.2001.00120.x · Cited by 2,507 · see citing works
The revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity
Conners, C. K., Sitarenios, G., Parker, J. D. A., & Epstein, J. N. (1998) · Journal of Abnormal Child Psychology · doi:10.1023/a:1022602400621 · Cited by 1,772 · see citing works
Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Goldman, L. S. (1998) · JAMA · doi:10.1001/jama.279.14.1100 · Cited by 1,082 · see citing works
Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature
Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003) · Pediatrics · doi:10.1542/peds.111.1.179 · Cited by 872 · see citing works
Self-citation
Drug Wanting: Behavioral Sensitization and Relapse to Drug-Seeking Behavior
Steketee, J. D., & Kalivas, P. W. (2011) · Pharmacological Reviews · doi:10.1124/pr.109.001933 · Cited by 649 · see citing works
The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes
Brookes, K., Xu, X., Chen, W., Zhou, K., Neale, B., Lowe, N., Aneey, R., Franke, B., Gill, M., Ebstein, R., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001869 · Cited by 533 · see citing works
Self-citation
Pharmacotherapy of Attention-deficit/Hyperactivity Disorder Reduces Risk for Substance Use Disorder
Biederman, J., Wilens, T., Mick, E., Spencer, T., & Faraone, S. V. (1999) · Pediatrics · doi:10.1542/peds.104.2.e20 · Cited by 493 · see citing works
Self-citation
Childhood Attention-Deficit/Hyperactivity Disorder and Future Substance Use Disorders: Comparative Meta-Analyses
Charach, A., Yeung, E., Climans, T., & Lillie, E. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.09.019 · Cited by 482 · see citing works
Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study
BIEDERMAN, J., WILENS, T., MICK, E., FARAONE, S. V., WEBER, W., CURTIS, S., THORNELL, A., PFISTER, K., JETTON, J. G., & SORIANO, J. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199701000-00013 · Cited by 476 · see citing works
Self-citation
Prospective Study of Tobacco Smoking and Substance Dependencies Among Samples of ADHD and Non-ADHD Participants
Lambert, N. M., & Hartsough, C. S. (1998) · Journal of Learning Disabilities · doi:10.1177/002221949803100603 · Cited by 465 · see citing works
Diagnostic Validity of the Drug Abuse Screening Test in the Assessment of DSM‐III Drug Disorders
Gavin, D. R., ROSS, H. E., & Skinner, H. A. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb03463.x · Cited by 454 · see citing works
European guidelines on managing adverse effects of medication for ADHD
(for the European Guidelines Group), Graham, J., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Döpfner, M., Hamilton, R., Hollis, C., et al. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-010-0140-6 · Cited by 374 · see citing works
Self-citation
Does the Treatment of Attention-Deficit/Hyperactivity Disorder With Stimulants Contribute to Drug Use/Abuse? A 13-Year Prospective Study
Barkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2003) · Pediatrics · doi:10.1542/peds.111.1.97 · Cited by 274 · see citing works
Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood.
Mannuzza, S., Klein, R. G., Truong, N. L., Moulton, J. L., Roizen, E. R., Howell, K. H., & Castellanos, F. X. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07091465 · Cited by 263 · see citing works
Role of Parent Support and Peer Support in Adolescent Substance Use: A Test of Mediated Effects.
Wills, T. A., Resko, J. A., Ainette, M. G., & Mendoza, D. (2004) · Psychology of Addictive Behaviors · doi:10.1037/0893-164x.18.2.122 · Cited by 254 · see citing works
Adolescent Substance Use in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder (ADHD) (MTA) as a Function of Childhood ADHD, Random Assignment to Childhood Treatments, and Subsequent Medication
Molina, B. S. G., Hinshaw, S. P., Eugene Arnold, L., Swanson, J. M., Pelham, W. E., Hechtman, L., Hoza, B., Epstein, J. N., Wigal, T., Abikoff, H. B., et al. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.12.014 · Cited by 246 · see citing works
Stimulant Therapy and Risk for Subsequent Substance Use Disorders in Male Adults With ADHD: A Naturalistic Controlled 10-Year Follow-Up Study
Biederman, J., Monuteaux, M. C., Spencer, T., Wilens, T. E., MacPherson, H. A., & Faraone, S. V. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07091486 · Cited by 239 · see citing works
Self-citation
Psychostimulant Treatment and Risk for Substance Abuse Among Young Adults with a History of Attention-Deficit/Hyperactivity Disorder: APopulation-Based, Birth Cohort Study
Katusic, S. K., Barbaresi, W. J., Colligan, R. C., Weaver, A. L., Leibson, C. L., & Jacobsen, S. J. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.764 · Cited by 175 · see citing works
The Relation Between Attention Deficit Hyperactivity Disorder and Substance Abuse: What Role Does Conduct Disorder Play?
Flory, K., & Lynam, D. R. (2003) · Clinical Child and Family Psychology Review · doi:10.1023/a:1022260221570 · Cited by 139 · see citing works
Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study: Follow-up of substance use in ADHD
Groenman, A. P., Oosterlaan, J., Rommelse, N., Franke, B., Roeyers, H., Oades, R. D., Sergeant, J. A., Buitelaar, J. K., & Faraone, S. V. (2013) · Addiction · doi:10.1111/add.12188 · Cited by 138 · see citing works
Self-citation
Effect of Prior Stimulant Treatment for Attention-Deficit/Hyperactivity Disorder on Subsequent Risk for Cigarette Smoking and Alcohol and Drug Use Disorders in Adolescents
Wilens, T. E., Adamson, J., Monuteaux, M. C., Faraone, S. V., Schillinger, M., Westerberg, D., & Biederman, J. (2008) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.162.10.916 · Cited by 136 · see citing works
Self-citation
Analysis of prevention program effectiveness with clustered data using generalized estimating equations.
Norton, E. C., Bieler, G. S., Ennett, S. T., & Zarkin, G. A. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.64.5.919 · Cited by 133 · see citing works
The impact of study design and diagnostic approach in a large multi-centre ADHD study. Part 1: ADHD symptom patterns
Müller, U., Asherson, P., Banaschewski, T., Buitelaar, J., Ebstein, R., Eisenberg, J., Gill, M., Manor, I., Miranda, A., Oades, R., et al. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-54 · Cited by 111 · see citing works
Self-citation
Is attention-deficit/hyperactivity disorder associated with illicit substance use disorders in male adolescents? A community-based case-control study
Szobot, C. M., Rohde, L. A., Bukstein, O., Molina, B. S. G., Martins, C., Ruaro, P., & Pechansky, F. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01850.x · Cited by 89 · see citing works
A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults
FARAONE, S. V., BIEDERMAN, J., WILENS, T. E., & ADAMSON, J. (2007) · Psychological Medicine · doi:10.1017/s0033291707000335 · Cited by 57 · see citing works
Self-citation
Transitions between tobacco and cannabis use among adolescents: A multi-state modeling of progression from onset to daily use
Mayet, A., Legleye, S., Chau, N., et al. (2011) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.06.009 · Cited by 42 · see citing works
The Impact of Conduct Disorder and Stimulant Medication on Later Substance Use in an Ethnically Diverse Sample of Individuals with Attention-Deficit/Hyperactivity Disorder in Childhood
Harty, S. C., Ivanov, I., Newcorn, J. H., & Halperin, J. M. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2010.0074 · Cited by 36 · see citing works
No increase in long-term risk for nicotine use disorders after treatment with methylphenidate in children with attention-deficit/hyperactivity disorder (ADHD): evidence from a non-randomised retrospective study
Huss, M., Poustka, F., Lehmkuhl, G., & Lehmkuhl, U. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0872-3 · Cited by 36 · see citing works
Genetic and Environmental Influences Underlying Externalizing Behaviors, Cigarette Smoking and Illicit Drug Use Across Adolescence
Korhonen, T., Latvala, A., Dick, D. M., Pulkkinen, L., Rose, R. J., Kaprio, J. A., & Huizink, A. C. (2012) · Behavior Genetics · doi:10.1007/s10519-012-9528-z · Cited by 33 · see citing works
Does the medicating ADHD increase or decrease the risk for later substance abuse?
Wilens, T. E. (2003) · Revista Brasileira de Psiquiatria · doi:10.1590/s1516-44462003000300001 · Cited by 30 · see citing works
Erratum: The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes
Brookes, K. J., Xu, X., Chen, W., Zhou, K., Neale, B. M., Lowe, N., Anney, R., Franke, B., Gill, M., Ebstein, R. P., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001902 · Cited by 10 · see citing works
Self-citation

Flagged first, then by citations

Research works printed but not linked: 1

[17]17. Wilens TE, Adamson J, Monuteaux MC, Faraone SV, Schillinger M, Westerberg D, et al. Effect of prior stimulant treatment for attention- deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. Arch Pediatr Adolesc Med 2008; 162: 916-21.

Sorted by citations

Attention-deficit/hyperactivity disorder
Faraone, S. V., Asherson, P., Banaschewski, T., Biederman, J., Buitelaar, J. K., Ramos-Quiroga, J. A., Rohde, L. A., Sonuga-Barke, E. J. S., Tannock, R., & Franke, B. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.20 · Cited by 1,479 · see citing works
Self-citation
Trends in the Parent-Report of Health Care Provider-Diagnosed and Medicated Attention-Deficit/Hyperactivity Disorder: United States, 2003–2011
Visser, S. N., Danielson, M. L., Bitsko, R. H., Holbrook, J. R., Kogan, M. D., Ghandour, R. M., Perou, R., & Blumberg, S. J. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.09.001 · Cited by 1,263 · see citing works
ADHD Medication and Substance-Related Problems
Quinn, P. D., Chang, Z., Hur, K., Gibbons, R. D., Lahey, B. B., Rickert, M. E., Sjölander, A., Lichtenstein, P., Larsson, H., & D’Onofrio, B. M. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.16060686 · Cited by 187 · see citing works
Risk of unintentional injuries in children and adolescents with ADHD and the impact of ADHD medications: A systematic review and meta-analysis
Ruiz-Goikoetxea, M., Cortese, S., Aznarez-Sanado, M., Magallón, S., Alvarez Zallo, N., Luis, E. O., de Castro-Manglano, P., Soutullo, C., & Arrondo, G. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.11.007 · Cited by 175 · see citing works
Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
Ottosen, C., Petersen, L., Larsen, J. T., & Dalsgaard, S. (2016) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2015.12.010 · Cited by 67 · see citing works
Stimulant treatment of ADHD and cigarette smoking: a meta-analysis
Schoenfelder, E. N., Faraone, S. V., & Kollins, S. H. (2014) · Pediatrics · doi:10.1542/peds.2014-0179 · Cited by 55 · see citing works
Self-citation
Neuroimaging the neural correlates of increased risk for substance use disorders in attention-deficit/hyperactivity disorder-A systematic review: Neuroimaging ADHD at High Risk for SUD
Adisetiyo, V., & Gray, K. M. (2017) · The American Journal on Addictions · doi:10.1111/ajad.12500 · Cited by 49 · see citing works
An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder
Groenman, A. P., Schweren, L. J. S., Dietrich, A., & Hoekstra, P. J. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1301928 · Cited by 46 · see citing works
Self-citation
Challenges of Treating ADHD with Comorbid Substance Use Disorder: Considerations for the Clinician
Barbuti, M., Maiello, M., Spera, V., Pallucchini, A., Brancati, G., Maremmani, A., Perugi, G., & Maremmani, I. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093096 · Cited by 47 · see citing works
Association Between Stimulant Treatment and Substance Use Through Adolescence Into Early Adulthood.
Molina, B. S. G., Kennedy, T. M., Howard, A. L., Swanson, J. M., Arnold, L. E., Mitchell, J. T., Stehli, A., Kennedy, E. H., Epstein, J. N., Hechtman, L. T., et al. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.2157 · Cited by 42 · see citing works
Stimulant treatment profiles predicting co-occurring substance use disorders in individuals with attention-deficit/hyperactivity disorder
Groenman, A. P., Schweren, L. J. S., Weeda, W., Luman, M., Noordermeer, S. D. S., Heslenfeld, D. J., Franke, B., Faraone, S. V., Rommelse, N., Hartman, C. A., et al. (2019) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-019-01283-y · Cited by 36 · see citing works
Self-citation
Amphetamine disrupts dopamine axon growth in adolescence by a sex-specific mechanism in mice
Reynolds, L. M., Hernandez, G., MacGowan, D., Popescu, C., Nouel, D., Cuesta, S., Burke, S., Savell, K. E., Zhao, J., Restrepo-Lozano, J. M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39665-1 · Cited by 30 · see citing works
Treatment of Adolescents with Concurrent Substance Use Disorder and Attention-Deficit/Hyperactivity Disorder: A Systematic Review
Özgen, H., Spijkerman, R., Noack, M., Holtmann, M., Schellekens, A., Dalsgaard, S., van den Brink, W., & Hendriks, V. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173908 · Cited by 27 · see citing works

PMH68 IMPACT OF FAMILY STRUCTURE ON STIMULANT USE AMONG CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER
Rabbani, A., & Alexander, G. C. (2009) · Value in Health · doi:10.1016/s1098-3015(10)73988-7
Effects of Maternal Stimulant Medication on Observed Parenting in Mother–Child Dyads With Attention-Deficit/Hyperactivity Disorder
Chronis-Tuscano, A. M., Rooney, M. E., Seymour, K. E., Jones, H. A., Pian, J., Robb, A. S., Efron, L. A., Conlon, C. J., & Stein, M. A. (2010) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2010.486326 · Cited by 33 · see citing works
Faculty Opinions recommendation of Executive functioning in children with attention-deficit/hyperactivity disorder: combined type with and without a stimulant medication history.
Hogan, A. M. (2008) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1123208.580346
High Dose Stimulant Medication for the Management of Attention Deficit/Hyperactivity Disorder (ADHD): A Retrospective Cohort Study
(2018) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.13946_22
Contributions of Maternal Attention-Deficit Hyperactivity and Oppositional Defiant Disorder Symptoms to Parenting
Miller, R. W., Gondoli, D. M., Gibson, B. S., Steeger, C. M., & Morrissey, R. A. (2017) · Parenting · doi:10.1080/15295192.2017.1369809 · Cited by 4 · see citing works

Authors: Groenman, A. P., Oosterlaan, J., Rommelse, N. N. J., Franke, B., Greven, C. U., Hoekstra, P. J., Hartman, C. A., Luman, M., Roeyers, H., Oades, R. D., Sergeant, J. A., Buitelaar∗, J. K., & Faraone∗, S. V.
Affiliations: Vrije Universiteit Amsterdam (NL)
Radboud University Nijmegen (NL)
University of London (GB)
University Medical Center Groningen (NL)
Ghent University (BE)
University of Duisburg-Essen (DE)
Corresponding author: Groenman, Annabeth P.
ORCID: Groenman, Annabeth P.
Oosterlaan, Jaap
Rommelse, Nanda N. J.
Franke, Barbara
Greven, Corina U.
Hoekstra, Pieter J.
Hartman, Catharina A.
Luman, Marjolein
Roeyers, Herbert
Sergeant, Joseph A.
Venue: British Journal of Psychiatry
Publisher: Royal College of Psychiatrists
Published: 2013-08
Volume: 203
Issue: 2
Pages: 112-119
ISSN: 0007-1250 (ISSN-L)
1472-1465
DOI: 10.1192/bjp.bp.112.124784
OpenAlex: W2122377852
Semantic Scholar: 4cad71b69987a21647f3aaf96c7a2d7dfbd1c67f
Cited by: 85
References: 37
Citations by year: 2026: 2 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 5 · 2021: 2 · 2020: 7 · 2019: 4 · 2018: 6 · 2017: 16 · 2016: 9 · 2015: 8 · 2014: 12 · 2013: 2
FWCI: 7.32
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.cambridge.org/core/terms (unspecified, 1615 d)
Locations: The British Journal of Psychiatry (publishedVersion)
PubMed (publishedVersion)
Pure Amsterdam UMC (publishedVersion)
University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
VU Research Portal (publishedVersion)
Ghent University Academic Bibliography (Ghent University) (submittedVersion, other-oa)
Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
Radboud Repository (Radboud University) (submittedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
DuEPublico (University of Duisburg-Essen) (submittedVersion)
University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Funders: Bristol-Myers Squibb
Eli Lilly and Company
Pfizer
Syracuse University
State University of New York
ZonMw (60-60600-97-193, 60600)
Shire
Servier
National Institutes of Health
State University of New York Upstate Medical University
Cilag
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
Keywords: attention deficit hyperactivity disorder, stimulant medication, substance use disorders, nicotine dependence, adolescents, conduct disorder, oppositional defiant disorder, long-term outcomes
MeSH terms: Adolescent, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Prospective Studies, Risk, Tobacco Use Disorder, Case-Control Studies, Conduct Disorder, Attention Deficit and Disruptive Behavior Disorders, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks